These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 11601159

  • 1. Mucolytic therapy in cystic fibrosis.
    Wallis C.
    J R Soc Med; 2001; 94 Suppl 40(Suppl 40):17-24. PubMed ID: 11601159
    [No Abstract] [Full Text] [Related]

  • 2. Dornase alfa for cystic fibrosis.
    Yang C, Chilvers M, Montgomery M, Nolan SJ.
    Cochrane Database Syst Rev; 2016 Apr 04; 4():CD001127. PubMed ID: 27043279
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I.
    King M, Dasgupta B, Tomkiewicz RP, Brown NE.
    Am J Respir Crit Care Med; 1997 Jul 04; 156(1):173-7. PubMed ID: 9230743
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evidence-based medicine.
    Marino JT.
    Pediatr Pulmonol; 1998 Sep 04; 26(3):231-3. PubMed ID: 9773922
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The expanding armamentarium of drugs to aid sputum clearance: how should they be used to optimize care?
    Bilton D, Stanford G.
    Curr Opin Pulm Med; 2014 Nov 04; 20(6):601-6. PubMed ID: 25221855
    [Abstract] [Full Text] [Related]

  • 9. Statistical analysis of the long-term effects of recombinant human deoxyribonuclease on pulmonary function in cystic fibrosis patients.
    Chen JJ, Hamilton SA.
    J Biopharm Stat; 2000 Aug 04; 10(3):287-97. PubMed ID: 10959912
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Medium term treatment of stable stage cystic fibrosis with recombinant human DNase I.
    Shah PL, Scott SF, Fuchs HJ, Geddes DM, Hodson ME.
    Thorax; 1995 Apr 04; 50(4):333-8. PubMed ID: 7785003
    [Abstract] [Full Text] [Related]

  • 17. Deoxyribonuclease for cystic fibrosis.
    Kearney CE, Wallis CE.
    Cochrane Database Syst Rev; 2000 Apr 04; (2):CD001127. PubMed ID: 10796748
    [Abstract] [Full Text] [Related]

  • 18. Dornase alpha and survival of patients with cystic fibrosis.
    McIntyre AM.
    Hosp Med; 1999 Oct 04; 60(10):736-9. PubMed ID: 10656067
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.